StoneX Group’s AstraZeneca AZN Stock Holding History

StoneX Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$377K	Buy	+1,995	New	+$375K	0.02%	698
2026 Q1	–	Sell	-1,506	Closed	-$278K	–	937
2025 Q4	$278K	Buy	1,506 +184	+14%	+$32.3K	0.01%	733
2025 Q3	$203K	Buy	+1,322	New	+$200K	0.01%	821
2025 Q2	–	Sell	-1,523	Closed	-$224K	–	883
2025 Q1	$224K	Buy	+1,523	New	+$220K	0.01%	736
2022 Q1	–	Sell	-1,900	Closed	-$221K	–	625
2021 Q4	$221K	Buy	+1,900	New	+$224K	0.03%	491
2021 Q3	–	Sell	-17,503	Closed	-$2.1M	–	471
2021 Q2	$2.1M	Buy	+17,503	New	+$1.92M	0.31%	64
2017 Q3	–	Sell	-16,275	Closed	-$1.11M	–	185
2017 Q2	$1.11M	Buy	16,275 +9,683	+147%	+$632K	0.35%	99
2017 Q1	$360K	Sell	6,592 -227	-3%	-$13.2K	0.81%	45
2016 Q4	$373K	Sell	6,819 -415	-6%	-$23.6K	0.65%	60
2016 Q3	$475K	Buy	+7,234	New	+$473K	1.06%	43

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

StoneX Group's AZN Position: Q2 2026 in Review

StoneX Group opened a new position in AstraZeneca (AZN) in Q2 2026: 1,995 shares worth $377K. The stake represents 0.02% of the portfolio and ranks #698 among its holdings. This is a return to the name: StoneX Group previously reported a position in AZN as recently as Q4 2025.

StoneX Group first reported a position in AZN in Q3 2016 and has held it in 10 quarters since. The position peaked at $2.1M in Q2 2021. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

StoneX Group held 1,995 shares of AstraZeneca worth $377K as of Q2 2026.
AstraZeneca was a new StoneX Group position in Q2 2026.
AstraZeneca made up 0.02% of StoneX Group's portfolio in Q2 2026, its #698 holding.
StoneX Group first reported a position in AstraZeneca in Q3 2016 and has held it in 10 quarters since.
StoneX Group's AstraZeneca position peaked at $2.1M in Q2 2021.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.